Shopping Cart
Remove All
Your shopping cart is currently empty
Boserolimab (MK-5890) is a humanized monoclonal antibody targeting CD27 with agonistic activity. It partially blocks the binding of soluble CD70 to CD27-expressing membranes and can be used in lung cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $163 | - | In Stock | |
| 5 mg | $496 | - | In Stock | |
| 10 mg | $795 | - | In Stock | |
| 25 mg | $1,180 | - | In Stock | |
| 50 mg | $1,580 | - | In Stock |
| Description | Boserolimab (MK-5890) is a humanized monoclonal antibody targeting CD27 with agonistic activity. It partially blocks the binding of soluble CD70 to CD27-expressing membranes and can be used in lung cancer research. |
| In vitro | Boserolimab (0-20 µg/mL, 3 days) partially blocked binding of soluble CD70 to CD27-expressing membranes (IC50=0.24 nM), activated the NF-κB signaling pathway, promoted T cell activation, and enhanced IFNγ secretion [1]. |
| In vivo | Boserolimab (5 mg/kg, intraperitoneal injection, 3 times weekly for 3–7 doses) enhances immune responses and exhibits antitumor activity against MC38 in a mouse xenograft model [1]. |
| Synonyms | MK-5890 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | CD27 |
| Cas No. | 2444297-08-7 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.